Using machine learning techniques to explore H-1-MRS data of brain tumors by González Navarro, Félix Fernando & Belanche Muñoz, Luis Antonio
Using Machine Learning Techniques to Explore 1H-MRS data of Brain Tumors
Fe´lix Fernando Gonza´lez-Navarro and Lluı´s A. Belanche-Mun˜oz
Dept. de Llenguatges i Sistemes Informa`tics
Universitat Polite`cnica de Catalunya
Barcelona, Spain
{fgonzalez, belanche}@lsi.upc.edu
Abstract—Machine learning is a powerful paradigm to ana-
lyze Proton Magnetic Resonance Spectroscopy (1H-MRS) spec-
tral data for the classification of brain tumor pathologies. An
important characteristic of this task is the high dimensionality
of the involved data sets. In this work we apply filter feature
selection methods on three types of 1H-MRS spectral data:
long echo time, short echo time and an ad hoc combination
of both. The experimental findings show that feature selection
permits to drastically reduce the dimension, offering at the
same time very attractive solutions both in terms of prediction
accuracy and the ability to interpret the involved spectral
frequencies. A linear dimensionality reduction technique that
preserves the class discrimination capabilities is additionally
used for visualization of the selected frequencies.
Keywords-Machine Learning; Feature Selection; Proton
Magnetic Resonance Spectroscopy; Classification; Visualiza-
tion;
I. INTRODUCTION
Proton Magnetic Resonance Spectroscopy or 1H-MRS is
a non-invasive technique that provides information about the
biochemical profile (metabolites and lipids) of brain tissue;
1H-MRS data has the appearance of a plot of peaks along
the x-axis, with the peak position depending on the resonant
frequency of the associated metabolite. As a result this
technique provides a valuable tool in discovering or telling
from possible disease processes [1] and serves as a support to
other diagnostic methods like Magnetic Resonance Imaging
(MRI) in clinical practice [2]. An example of a 1H-MRS
data set is depicted in Fig. I.There are several examples in
the literature that use machine learning (ML) techniques in
telling different classes of brain tumors. First attempts using
1H-MRS data in assessing human brain tumors in vivo are
back to [3]. It was found that spectra differ significantly from
normal brain spectra and between tumors by detecting the
presence/absence of different metabolites. Even though no
ML analysis of spectra was done in establishing these dif-
ferences, it was concluded that 1H-MRS spectroscopy may
help to differentiate tumors for diagnostic and therapeutic
purposes, limiting the need for invasive and risky diagnostic
procedures such as biopsies. ML techniques have been used
in order to automate the classification task. Linear discrim-
inant analysis (LDA) (e.g. [5], [6]) and artificial neural
networks (e.g. [7], [8]) are commonly used methods. Later
studies perform dimensionality reduction, either considering
the peak signals, ratios between peak signals or feature
extraction [14], [13]. First studies in performing explicit
feature selection used a modification of the well-known
Forward Selection method to select spectral points [9]. More
recently, filter methods such as the Fisher criterion and the
Relief algorithm, among others, have been considered [2].
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Figure 1. Example mean spectra for a long echo time 1H-MRS data
set. Some metabolites –resulting products of metabolic processes– are
indicated in the spectra. For example: Creatine (tCre), a marker of oxidative
metabolism of cells; Choline, which is a combination of multiple metabo-
lites and is elevated in all brain tumors; Lipids (Lip), seen in condition of
necrosis.
Due to the relatively high dimensionality of 1H-MRS data
(up to 500 spectral features), these efforts use dimensionality
reduction methods such as PCA to lower the complexity
of the problem; a recognized drawback is the difficulty to
interpret the solution in original terms; moreover, PCA is not
designed to preserve class separability [9]. However, data
projection techniques that preserve the class discrimination
achieved by a classifier are very welcome since they can
be used to visualize the solutions generated by the feature
selection process. In this work we develop a feature selection
method to generate relevant subsets of spectral frequencies.
The evaluation of subsets is based on entropic measures that
treat single spectral frequencies as the features. The goal
is to find attractive solutions in terms of low numbers of
frequencies, high prediction accuracy and the interpretability
of the selected spectral frequencies. The combination of
feature selection and classification aims at obtaining simple
models (in terms of low numbers of features) capable
of good generalization. We also aim to progress in the
comparison of MRS data acquired at different echo times,
as well as in the comparison of these with data that combine
both echo times.
Figure 2. Left: Mutual information between two variables X,Y as shared
conditional entropy. Right: Mutual information between two variables X,Z
in the presence of a class variable Y .
II. PRELIMINARIES
The mutual information (I) can be interpreted as a mea-
sure of the information that a random variable has or
explains about another one:
I(X;Y ) = H(Y )−H(Y |X) = EX,Y [log p(x,y)p(x)p(y) ] (1)
where H denotes the entropy. Note that I(X;X) = H(X),
since H(X|X) = 0 and I(X;Y ) = I(Y ;X). These
concepts are graphically represented in Fig. 2 (left). It can
be seen that by increasing I(X;Y ), H(Y |X) decreases; in
other words, there is a reduction in the uncertainty of Y
due to the action of X . The computation of MI can be
extended from the bivariate to the multivariate case, of a
number n ≥ 2 of variables against another one:
I(X1, . . . , Xn;Y ) =
n∑
i=1
I(Xi;Y |X1, . . . , Xi−1)
= H(Y )−H(Y |X1, . . . , Xn) (2)
Conditional I is expressed in the natural way, by condition-
ing in (1):
I(X;Y |Z) = H(Y |Z)−H(Y |X,Z) (3)
The MI in the bi-variate case has been successfully used
in feature selection, as a way to measure the influence that
a feature has over the class or target variable. Sometimes
a normalized variant is used, given by CXY = I(X;Y )H(Y ) ,
where Y is the class or target variable, commonly known as
coefficient of constraint or uncertainty coefficient (note that
the maximum value that I(X;Y ) can take is H(Y )). This
coefficient has been used to create a measure of relevance for
feature subsets with respect to a class feature (see e.g. [11]).
Instead of conditioning, in this work we propose to calculate
the MI between a class variable Y and two variables X and
Z, as shown in Fig. 2 (right). The shaded area represents
I(Y ;X,Z), the information that X,Z explain about Y :
I(Y ;X,Z) = H(Y )−H(Y |X,Z)
= H(Y ) + H(X,Z)−H(X,Y,Z) (4)
Given that I(Y ;X,Z) ≤ 1 and that H(Y ) acts as the
baseline reference, it is wise to normalize it as:
R(Y ;X,Z) =
H(Y ) + H(X,Z)−H(X,Y,Z)
H(Y )
(5)
An index of relevance R is obtained that evaluates the
influence of two variables with respect to a class vari-
able. It takes values between zero (no relevance) and one
(maximum relevance). In order for this expression to be
of practical use from the feature selection point of view,
it needs to be extended to the multivariate case. The mutual
information between a subset of variables and the class
variable is computed by generating first a “super-feature”,
obtained considering the concatenation of each combination
of possible values of its forming features. In symbols, let
X = {X1, ...,Xn} be the full feature set and consider
a subset τ = {τ1, · · · , τk} ⊆ X . A single feature Vτ
can be obtained uniquely, whose possible values are the
concatenations of all possible values of the features in τ
(for completeness, define V∅ = ∅). The expression in eq. (5)
can be determined as a simple bivariate case: an index of
relevance of a feature Xi ∈ X to a class Y with respect to
a subset τ ⊂ X \Xi is given by:
R(Xi;Y |τ) = H(Y ) + H(τ,Xi)−H(τ, Y,Xi)
H(Y )
(6)
The use of the super-feature allows faster computations,
that are not essential for its understanding. A detailed imple-
mentation can be found in [19]. This way of calculating fea-
ture subset relevance is used to evaluate subsets of spectra,
embedded into a filter forward-search strategy, conforming
the BS4 algorithm, a supervised filter independent of the
search strategy or the a posteriori inducer, described below.
A. Algorithm BS4: Best Spectral Subset Search Strategy
Algorithm BS4–which stands for Best Spectral Subset
Search Strategy–, is to be used with the index of relevance
defined in (6); see Algorithm 1. It begins by selecting
the best feature that maximizes its relevance with respect
to the class feature (line 2-4). Then a forward search is
conducted in which, at every step, the feature that provides
the maximum value of relevance when added to the current
subset is selected (line 7). It is possible that, at the end of
a step, more that one feature renders the same value for
relevance (lines 8-12). If this is the case, then the feature
that produces the minimum redundancy of information is
chosen (line 9). In case this newly added feature brings a
positive benefit, it is added to the current subset (lines 15-
16). The algorithm stops whenever the index of relevance
can no longer be augmented: either the maximum value has
been reached, no increment in current relevance is possible
or we have run out of features (line 20). This work was
aimed to achieve results that reflect the true behavior of
the system as much as possible; in other words, to obtain
reliably relevant features. We therefore advocate for the use
of bootstrapping techniques in the feature selection process.
Bootstrap resampling techniques are used to yield mean
performance estimates and their variability, and thus a more
reliable measure of predictive ability. These methods are also
well-suited for the construction of standard error estimates
and confidence intervals when sample size is small or the
distribution of the statistic is unknown.
Algorithm 1 BS4 Best Spectral Subset Search Strategy
1: Input: X = {X1, . . . , Xn}: Feature set;
C: Class feature
2: φ ← argmax
f∈X
H(C)−H(f, C)
H(C)
3: Φ ← {φ}: Current best subset
4: R ← H(C)−H(Φ,C)
H(C)
: Current best relevance
5: S ← false
6: repeat
7: φ ←
{
argmax
f∈X\Φ
H(C) + H(Φ, f)−H(Φ, C, f)
H(C)
}
8: if |φ| > 1 then
9: φ+ ← argmin
f∈φ
I(Φ, f)
10: else
11: φ+ ← φ
12: end if
13: R+ ← H(C)−H(Φ∪{φ+},C)
H(C)
14: if R+ > R then
15: R ← R+
16: Φ ← Φ ∪ {φ+}
17: else
18: S ← true
19: end if
20: until R+ = 1 ∨ S ∨ |Φ| = n
21: Output: Φ : Best Spectral Subset (BSS)
The original 1H-MRS data sets S were used to generate
B = 5, 000 bootstrap samples S1, . . . , SB that play the
role of training sets in the feature selection process: each
relevance value calculated in the algorithm BS4 (lines 4,
7 and 13) is the average across the B bootstrap samples,
i.e., the average behavior of a feature is used to guide and
stabilize the algorithm.
III. EXPERIMENTAL WORK
A. Data sets
MRS provides a detailed metabolic fingerprint of the
tumor-affected tissue that varies according to the echo time
of the acquisition and can be used to characterize these
pathologies. The echo time is an influential parameter in
1H-MRS spectra acquisition. In short-echo time spectra
(typically 20-40 ms) some metabolites are better evaluated
–e.g. lipids, myo-inositol, glutamine and glutamate–. How-
ever, there may be numerous overlapping resonances –e.g.
glutamate/glutamine at 2.2 ppm and NAA at 2.01 ppm–
which make the spectra difficult to interpret [6]. A long-
echo time (270-288 ms) yields less metabolites but also less
baseline distortion, resulting in a more readable spectrum.
The analyzed 1H-MRS data were extracted from a database
resulting from the INTERPRET European research project.
For details on data acquisition and processing, please refer
to [12]. The basic data characteristics are detailed as follows:
• 195 single voxel long-echo time LET spectra acquired
in vivo from brain tumor patientsy, including: menin-
giomas (55 cases), glioblastomas (78), metastases (31),
astrocytomas Grade II (20), oligoastrocytomas Grade II
(6) and oligodendrogliomas Grade II (5);
• 217 single voxel short-echo time SET spectra: menin-
giomas (58 cases), glioblastomas (86), metastases (38),
astrocytomas Grade II (22), oligoastrocytomas Grade II
(6) and oligodendrogliomas Grade II (7).
• 195 single voxel long/short-echo time LSET spectra,
obtained by merging the 195 common observations of
the two previous data sets.
Class labeling was performed according to the World
Health Organization for diagnosing brain tumors by
histopathological analysis of a biopsy sample. Both spectra
were grouped into three superclasses: high-grade malignant
tumors (metastases and glioblastomas), low-grade gliomas
(astrocytomas, oligodendrogliomas and oligoastrocytomas)
and meningiomas.
B. Experimental setup
In order to compute the necessary entropies, a discretiza-
tion process is needed. This change of representation does
not often result in a significant loss of accuracy (sometimes
significantly improves it [17], [18]); it additionally offers
reductions in learning time [20]. In this work, the data
sets were discretized using the CAIM algorithm, which
was selected for two reasons: it is designed to work with
supervised data, and does not require the user to define a
specific number of intervals [21]. First, algorithm BS4 is
applied to the discretized bootstrap samples to obtain the
BSSs (one for each data set). Then the classifier development
stage is conducted using the continuous frequencies (both
in the full set and in the obtained BSSs). Five different
classifiers were evaluated by means of 10 times 10-Fold
Cross Validation (10x10cv): the nearest-neighbor technique
with Euclidean metric (kNN) and parameter k (number
of neighbors), the Naı¨ve Bayes classifier (NB), a Linear
Discriminant classifier (LDC), Support Vector Machine with
linear kernel (lSVM) and parameter C (regularization con-
stant) and Support Vector Machine with radial basis function
kernel (rSVM) and parameter C (regularization constant) and
σ2 (smoothing in the kernel function).
Data set |BSS| CPU time ppm
LET 16 5min 1.27, 1.23, 1.32, 1.21, 1.30, 1.17, 1.51, 1.55, 2.14
3.77, 3.03, 0.92, 1.44, 0.94, 2.20, 2.94
SET 16 5min 2.37, 1.32, 1.29, 2.35, 2.31, 1.34, 1.25, 1.23, 2.25
2.24, 1.38, 3.77, 3.81, 2.54, 3.03, 3.60
LSET 17 12min S2.37, S1.27, S1.23, S1.30, S2.31, S2.39, S2.43
S1.36, L1.27, S3.05, S2.22, S3.03, S2.27, S3.55
S2.48, S3.77
Table I
FINAL SELECTED BSSS PER DATA SET. LEFT TO RIGHT READING
INDICATES THE ORDER OF SELECTION IN THE FEATURE SELECTION
PROCESS. FOR LSET DATA, THE ORIGIN IS INDICATED BY A PREFIX (L
OR S).
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Figure 3. BSS for LET(Top), SET (Middle), LSET (Bottom) data set.
Mean spectra for 3 classes are indicated.
C. Results and discussion
The results of the feature selection process are presented
in Table I: for each 1H-MRS data set, the obtained BSSs
are detailed. Note the drastic reduction in the dimension
and that subset sizes are very similar. For LSET data, all
but one of the spectral points belong to the SET spectrum.
Overall computation times are also shown. The positions of
these selected spectral points in the spectrum are indicated
in Figure 3. In LET, mostly fall in Glycine Myo-inositol
region (3.77 ppm), Creatine peak (3.03, 2.94), Glutamete-
Glutamine compunds (2.20, 2.14), Alanine peak (1.55, 1.51)
and the rest fall in Lactate en Lipids regions. In SET,
Data set NB kNN LDC lSVM rSVM
Using BSS
LET 83.2±0.06 86.0±0.06 83.0±0.08 87.9±0.09 88.0±0.05
SET 86.0±0.05 87.9±0.04 88.8±0.09 89.4±0.08 89.6±0.06
LSET 85.1±0.05 89.4±0.05 86.7±0.12 90.1±0.03 91.0±0.05
Using the whole spectrum
LET 84.9±0.09 86.3±0.05 79.8±0.22 89.9±0.04 90.0±0.06
SET 82.6±0.06 87.8±0.06 84.5±0.13 90.0±0.08 90.4±0.08
LSET 15.9±0.01 89.4±0.09 * 90.6±0.04 90.7±0.08
Data set NB kNN LDC lSVM rSVM
Using BSS
LET (82.7,83.6) (85.5,86.5) (82.4,83.7) (87.2,88.6) (87.7,88.5)
SET (85.6,86.4) (87.5,88.1) (88.0,89.5) (88.7,90.0) (89.1,90.0)
LSET (84.7,85.5) (89.0,89.9) (85.7,87.7) (89.8,90.4) (90.4,91.2)
Using the whole spectrum
LET (84.1,85.6) (85.9,86.7) (78.0,81.6) (89.5,90.2) (89.5,90.5)
SET (82.2,82.9) (87.3,88.3) (83.5,85.6) (89.4,90.6) (89.8,91.0)
LSET (15.7,16.0) (88.6,90.1) n.a. (90.3,90.9) (90.0,91.3)
Table II
TOP:10X10CV ACCURACY (IN %) AND STANDARD ERROR PER DATA SET
AND CLASSIFIER USING THE SELECTED SUBSETS OF SPECTRAL POINTS
(TABLE I) AND THE WHOLE SPECTRUM. BOTTOM: CONFIDENCE
INTERVALS. ASTERISK INDICATES NUMERICAL PROBLEMS.
True LSET(17)+rSVM
Class LG HG ME
LG 7 1 0
HG 1 29 0
ME 0 1 14
True LSET(390)+rSVM
Class LG HG ME
LG 7 1 0
HG 1 29 0
ME 0 1 14
Table III
TEST SET CONFUSION MATRIX FOR LSET WITH 17 FEATURES –SEE
TABLE I– AND RSVM INDUCER; AND LSET USING THE WHOLE
SPECTRUM (390 FEATURES) AND RSVM.
spectral points are in Glutamate-Glutamine and alanine re-
gion (3.81, 3.77), Myo-Inositol and Glycine (3.60), Creatine
(3.03), Glutamate-Glutamine and N-acetylaspartate (2.54,
2.37, 2.35, 2.31, 2.25, 2.24) and the rest in the Lactate and
Mobile Lipids region.
The 10x10cv accuracy rate is presented in Table II for
each data set. It is seen that the rSVM apparently delivers
the best results. Special attention deserves LSET where
an accuracy as high as 91% is achieved, exceeding other
accuracies reported elsewhere –see section D. The lSVM and
kNN classifiers also show a good performance. A Wilcoxon
Signed-Rank Test is performed for the (null) hypothesis that
the median of the differences between rSVM errors and the
error of another classifier is zero, for every data set –see
Table IV. As it turns out, this hypothesis has to be rejected
at the 95% level when rSVM is compared against all other
classifiers, remarkably for all three data types. Also the p-
values indicate that classification capacities using the whole
spectrum of features and the rSVM classifier in the LSET
data set are approximately the same –Table IV, right. This
gives a strong support to the fact that by reduction of this
problem to a very low dimensionality, a description of the
phenomenon as accurate as using the entire set of can be
achieved.
In a medical context, data visualization in a low-
dimensional representation space may become extremely
Data set (Classifier) NB kNN LDC lSVM
LET (rSVM) 0.002 0.002 0.002 0.496
SET (rSVM) 0.002 0.002 0.049 0.922
LSET (rSVM) 0.002 0.004 n.a. 0.002
Data set (Classifier) p-value
LET (rSVM) 0.002
SET (rSVM) 0.020
LSET (rSVM) 0.695
Table IV
WILCOXON SIGNED RANK TEST p-VALUES: LEFT: DIFFERENCES
BETWEEN THE RSVM VS. THE REST IN THE SELECTED SUBSETS.
RIGHT: DIFFERENCES BETWEEN THE RSVMS VS. THEMSELVES USING
THE WHOLE SPECTRUM.
important, helping radiologists to gain insights into what
undoubtedly is a complex domain. We use in this work a
method based on the decomposition of the scatter matrix -
arguably a neglected method for dimensionality reduction-
with the remarkable property of maximizing the separation
between the projections of compact groups of data (tumor
classes, in this work). This is a recently introduced method
that leads onto the definition of low-dimensional projective
spaces with good separation between classes, even when
the data covariance matrix is singular; further details about
this method can be found in [22]. Such visualization is
illustrated by the plots in Figure 4. These are scatter plots
of 2-D projections of the three classes (using the first two
eigenvectors of the scatter matrices).
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Figure 4. Projection of the data sets (using the selected feature subsets)
onto the first two eigenvectors of the scatter matrices as coordinate system.
Top-Left: LET, Top-right: SET, Bottom: LSET. Circles represent low-grade
gliomas; filled squares high-grade malignant tumors and stars meningiomas.
D. Past usage of these data sets
Previous work by [14] using PCA followed by LDC in
LET data showed that in distinguishing between high-grade
malignant tumors and meningiomas, a mean area under the
ROC curve of 0.94, using 6 principal components (PC) was
reached. The same method was used to distinguish between
high-grade malignant tumors and astrocytomas Grade II
(part of the low-grade gliomas super-class), obtaining a mean
AUC of 0.92, also using 6 PCs. [15] explored several feature
extraction methods, including ICA, PCA and wavelet trans-
formations and combined them systematically with different
classifiers such as LDC, SVMs and ensemble methods; re-
sults offered a 91% classification accuracy using regularized
linear regression, but in two-class problems. Regarding SET
data, [16] used PCA (10 PCs) , with LDC, kNN and a
Least-Squares SVM, reaching an 85% of accuracy in the
same three super-class problem; [14] reported a mean AUC
slightly than that for LET data: 0.95 with 4 PCs in the high-
grade malignant tumors and meningiomas problem, and 0.97
with 3 PCs in high-grade malignant tumors and astrocytomas
Grade II problem. In [10], PCA, Relief and a simple stepwise
method were used alongside with LDC and the LS-SVM.
Experimental results were: the combination LSET yielded
88.7% of accuracy; using LET data only, 82.5% of accuracy;
using SET data only, 88.8%.
E. Summary and discussion of findings
In view of all these experimental results, several findings
are now summarily presented:
1) Feature selection appears to be a viable avenue for
dimensionality reduction. With about a tenth of spec-
tral frequencies, the selected classifiers obtain mean
performance figures close or better to those using the
full set. This is specially important in the case of the
rSVM technique.
2) As stated in the introduction, most of the existing liter-
ature indicates an advantage in using SET information
over LET [5]. The present work adds strong support
to this finding, given that all the classifiers obtained
markedly better results for SET data against LET.
The combined use of both echo times yields similar
performance but using a lower number of frequencies.
3) The BS4 algorithm seems to work well, as it produces
rather sensible results with the reduced subsets. Its
simplicity and fast performance, independently from
the classifier or validation method, makes it a flexible
solution in analyzing this specific domain.
4) The resulting sets of selected spectral frequencies (Fig.
3) happen to be located in truly biologically relevant
regions, which permits an acceptable interpretation for
the solutions.
5) The discrimination ability of these sets can also be
subject of visual interpretation (Fig. 4), which defi-
nitely potentiates the supporting role to clinical prac-
tice.
IV. CONCLUSIONS AND FUTURE WORK
MRS is yet to become a standard method for day-to-
day clinical diagnosis of brain tumors, despite being a non-
invasive technique and one that provides rich information
about the biochemistry of the tumor pathology. In this study,
we report experimental results that support the practical
advantage of combining robust feature selection and clas-
sification ML technics in this field of research. An attractive
accurate classification is obtained with parsimonious and
interpretable subsets of spectral frequencies. A linear dimen-
sionality reduction technique that provides a data projection
–while preserving the class discrimination achieved by a
classifier– is also used in our study. The developed proposal
provides a drastic reduction in dimensionality while being
competitive or even sometimes improving on the perfor-
mance obtained using the full set of spectral frequencies.
This holds true for all the acquisition modalities considered:
short and long echo times, and the combination of both
by concatenation of spectra. These results are extremely
important as they make the diagnosis easily interpretable
in terms of a handful of spectral frequencies, most of them
associated to known metabolites. We have reached a step
beyond feature selection in improving the interpretability
of the results by providing a visualization method that pre-
serves the discrimination capability of the obtained classifier
models. Our classification results provide partial support to
similar studies in the literature as they show the comparative
advantage of using SET data or a combination of SET
and LET data. Future research will extend the use of the
proposed methodology to the analysis of other brain tumor
classification problems involving different pathologies and
pathology groupings.
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